SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(a)
(Amendment No. 2)
Meridian Medical Technologies, Inc.
--------------------------------------------------------------------------------
(Name of Issuer)
Common Stock, par value $0.10 per share
---------------------------------------------------------
(Title of Class of Securities)
589658 10 3
--------------------------------------------------------------------------------
(Cusip Number)
Stephen J. Kunst, Esq.
EM Industries, Incorporated
7 Skyline Drive
Hawthorne, NY 10532
(914) 592-4660
and
Klaus H. Jander, Esq.
Clifford Chance Rogers & Wells LLP
200 Park Avenue
New York, NY 10166
(212) 878-8000
--------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
November 30, 2000
--------------------------------------------------------------------------------
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on
Schedule 13G to report the acquisition that is the subject of this
Schedule 13D, and is filing this schedule because of Rule 13d-1(e),
13d-1(f) or 13d-1(g), check the following box |_|
Note. Schedules filed in paper format should include a signed
original and five copies of the schedule, including all exhibits. See
Rule 13d-7(b) for the other parties to whom copies are to be sent.
(Continued on following pages)
(Page 1 of 5 Pages)
<PAGE>
NYA 323074.1
--------------------------------- -------------------------------
CUSIP No. 589658 10 3 13D Page 2 of 5 Pages
--------------------------------- -------------------------------
============ ===================================================================
1. NAMES OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
EM. Industries, Incorporated
------------ -------------------------------------------------------------------
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)|_|
(b)|_|
------------ -------------------------------------------------------------------
3. SEC USE ONLY
------------ -------------------------------------------------------------------
4. SOURCES OF FUNDS
OO
------------ -------------------------------------------------------------------
5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEM 2(d) OR 2(e)
|_|
------------ -------------------------------------------------------------------
6. CITIZENSHIP OR PLACE OF ORGANIZATION
New York
------------------------- ------- ----------------------------------------------
7. SOLE VOTING POWER
NUMBER OF
UNITS 230,276(1)
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
------- ----------------------------------------------
8. SHARED VOTING POWER
0
------- ----------------------------------------------
9. SOLE DISPOSITIVE POWER
230,276(1)
------- ----------------------------------------------
10. SHARED DISPOSITIVE POWER
0
------------ -------------------------------------------------------------------
11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
230,276(1)
------------ -------------------------------------------------------------------
12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES
|-|
------------ -------------------------------------------------------------------
13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
7.6%
------------ -------------------------------------------------------------------
14. TYPE OF REPORTING PERSON
CO
============ ===================================================================
(1) Includes 29,038 shares of Common Stock of the issuer subject to presently
exercisable warrants.
<PAGE>
SCHEDULE 13D
FILED PURSUANT TO RULE 13d-1
OF THE GENERAL RULES AND REGULATIONS UNDER
THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED
This Amendment No. 2, which relates to shares of the common stock, par
value $0.10 per share (the "Common Stock") of Meridian Medical Technologies,
Inc. (the "Issuer") and is being filed by EM Industries, Incorporated,
supplements and amends the statement on Schedule 13D, dated November 20, 1996,
and originally filed with the Commission on December 2, 1996, and Amendment No.
1 thereto, dated October 24, 2000, and filed with the Commission on October 26,
2000.
Item 4. Purpose of the Transaction.
Item 4 of Schedule 13D is amended by the addition of the following:
As described in Amendment No. 1 to the Schedule 13D, EM intends to dispose of
the Common Stock and Warrants that it holds. Since the filing of Amendment No.
1, EM has sold, as of the date of this Amendment No. 2 to the Schedule 13D, a
total of 13,200 shares of Common Stock in market transactions at then prevailing
market prices, as set forth below in part (c) of Item 5. EM intends to continue
to dispose of its Common Stock and Warrants in an orderly fashion, as market
conditions permit and at prices acceptable to it. It will continue to hold its
Common Stock and Warrants to the extent that these objectives cannot be
achieved.
EM's decision to dispose of its interest in the Issuer was based on the fact
that its commercial relationship with the Issuer has been assigned to an
affiliate of EM, that EM's investment in the Issuer was unrelated to its current
strategic plans, and that its investment in the Issuer had appreciated in value,
and was not based on an evaluation of the Issuer's future prospects.
Item 5. Interest in Securities of the Issuer.
Part (a) of Item 5 of Schedule 13D is deleted and amended to read in its
entirety as follows:
(a) EM directly owns 201,238 shares of Common Stock and Warrants to purchase
29,038 shares of Common Stock (together, the "EM Common Shares"), which amounts
include the shares of Common Stock and Warrants acquired in the Merger plus
61,989 shares of Common Stock previously acquired by EM from STI in November
1992 in a privately negotiated transaction. Based in part upon information
provided by the Issuer and calculated in accordance with Rule 13d-3(d)(1) under
the Exchange Act, the EM Common Shares represent 7.6% of (i) the 2,994,930
shares of Common Stock outstanding on the date hereof plus (ii) the 29,038
shares of Common Stock issuable upon exercise of the Warrants.
(c) Paragraph (c) of Item 5 of the Schedule 13D is amended by the addition of
the following:
During the last sixty days, EM has sold a portion of its shares of Common Stock
in open market transactions as follows:
-------------------- -------------- -----------------
Date Sold No. of Price per Share
Shares Sold
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 7, 2000 500 $13.75
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 7, 2000 500 $13.50
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 7, 2000 300 $13.625
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 7, 2000 200 $13.50
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 8, 2000 5,000 $13.88
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 8, 2000 5,000 $14.00
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 10, 2000 100 $14.00
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 13, 2000 100 $14.00
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 14, 2000 1,000 $14.00
-------------------- -------------- -----------------
-------------------- -------------- -----------------
Nov. 14, 2000 500 $14,00
-------------------- -------------- -----------------
<PAGE>
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Dated: December 15, 2000
EM INDUSTRIES, INCORPORATED
By: /s/ Stephen J. Kunst
Name: Stephen J. Kunst
Title: Secretary and General Counsel
